Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. McGuff Pharmaceuticals, Inc.
FDA Inspection
•McGuff Pharmaceuticals, Inc.•January 26, 2024

McGuff Pharmaceuticals, Inc. – FDA Inspection, Jan 26, 2024

Record Details

This FDA Inspection record concerns McGuff Pharmaceuticals, Inc., with an inspection on January 26, 2024, issued by the Los Angeles District Office, covering human drugs.

Company
McGuff Pharmaceuticals, Inc.
Inspection Date
January 26, 2024
Product Type
Human Drugs
Office
Los Angeles District Office
People
  • Crystal Monroy
  • Heidy C. Perales (Company Rep)
  • Michael T. Cyrus (Investigator)
  • Pearl C. Ozuruigbo (Investigator)
View Company Profile

ID · 9da028b1-f0cc-456a-aa9e-f7ff6d6c6300

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1228033
FDA center
Human Drugs
Project area
New Drug Evaluation
Outcome
Form 483 issued

FDA Citations

6
  1. 21 CFR 211.100(a)Absence of Written Procedures
  2. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  3. 21 CFR 211.160(a)Following/documenting laboratory controls
  4. 21 CFR 211.192Investigations of discrepancies, failures
  5. 21 CFR 211.25(a)Training , Education , Experience overall
  6. 21 CFR 211.56(b)Written sanitation procedures lacking

Full citation text and observation details available on the Dashboard.

Other FDA inspections of McGuff Pharmaceuticals, Inc.

12
DateClassificationOfficeProject area
April 28, 2025OAILos Angeles District OfficeDrug Quality Assurance
August 20, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
November 22, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 26, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 2, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 12 other inspections on the company page
Other documents for McGuff Pharmaceuticals, Inc.
  • FDA Inspection 1268175 - 2025-04-28
  • FDA Inspection 1229677 - 2024-08-20
  • FDA Inspection 1110847 - 2019-11-22
  • FDA Inspection 1083919 - 2019-03-26
  • FDA Inspection 1013240 - 2017-06-02

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore McGuff Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.